Testing effectiveness (Phase 2)Active Not RecruitingNCT06448910
What this trial is testing
Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC
Who this might be right for
NSCLCLocally Advanced Lung Carcinoma
Fudan University 41